Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Qualgen, LLC
483
•Qualgen, LLC•May 10, 2017

Qualgen, LLC – FDA 483, May 10, 2017

Record Details

An FDA inspection of Qualgen, LLC, an outsourcing facility located in Edmond, OK, was conducted from April 17 to May 10, 2017. The inspection revealed significant deviations from regulatory requirements for sterile drug manufacturing, necessitating comprehensive corrective actions. Key observations included a recurring failure to thoroughly investigate unexplained discrepancies, such as multiple sterility failures for testosterone and estradiol pellets in 2016 and 2017, as well as environmental monitoring excursions and HEPA filter leaks. The firm's investigations were often incomplete, lacking documented root cause analyses or product impact assessments.

Furthermore, procedures to prevent microbiological contamination were deemed inadequate, with a lack of validation for the sterilization process of all pellet products. Critical processes like smoke studies were not representative of actual operations, and observations of improper handling of sterile components and unsanitary operator practices were noted. Deficiencies in maintaining controlled cleanroom environments were also identified, including incomplete third-party certification reports, incorrect personnel sampling techniques, numerous personnel monitoring excursions, undocumented pressure differentials, and the presence of rust on equipment in a cleanroom.

The inspection also found a lack of established and followed written procedures for in-process controls, specifically regarding the absence of statistical justification for sample sizes and the cessation of documenting individual pellet weight values. Finally, the firm failed to ensure appropriate laboratory testing for objectionable microorganisms; the sterility test methods used by their third-party vendor for both release testing and sterilization process validation were not validated, and bioburden determination was insufficient. Qualgen, LLC is required to address these systemic issues by enhancing its quality systems, validating critical processes, and improving environmental and personnel controls to meet federal regulatory standards for sterile drug production.

Company
Qualgen, LLC
Inspection date
May 10, 2017
Product type
Drugs
Office
Dallas District Office
Person
  • Margaret M. Annes
View Company Profile

ID · 72a3330a-d0fc-407b-833b-89ceab73a122

Violation Codes4
21 CFR 21021 CFR 211FD&C Act 801(a)(3)21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Qualgen, LLC
  • 483 - 2025-08-19August 19, 2025
  • 483 - 2024-03-19March 19, 2024
  • 483 - 2022-09-30September 30, 2022
  • 483 - 2015-09-17September 17, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Qualgen, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.